<DOC>
	<DOC>NCT00539773</DOC>
	<brief_summary>Phase II Trial of concurrent administration of intravesical BCG &amp; Interferon in the treatment and prevention of recurrence of superficial transitional carcinoma of the urinary bladder.</brief_summary>
	<brief_title>Phase II Trial of Concurrent Administration of Intravesical BCG &amp; Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Transitional Cell</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<criteria>Patients with superficial transitional carcinoma of the urinary bladder</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>